ASCO GU 2018: Serum miRNA to Predict Post-chemotherapy Viable Disease in Testicular Non-seminomatous Germ..
..Published 12 February 2018; San Francisco, CA (..com) Dr. Leao presented his work exploring the role of serum miRNA in predicting viable disease post-chemotherapy in non-seminoma germ cell tumors (NSGCT). This was a work led by Dr. Robert..
UroToday. Feb 12, 2018 13:56 UTC